Full Text View
Tabular View
No Study Results Posted
Related Studies
Arnogene: A Phosphocalcic Study in Dialysis (ARNOGENE)
This study is currently recruiting participants.
Verified by Hospices Civils de Lyon, March 2009
First Received: March 6, 2009   No Changes Posted
Sponsored by: Hospices Civils de Lyon
Information provided by: Hospices Civils de Lyon
ClinicalTrials.gov Identifier: NCT00858260
  Purpose

Searching for high morbi-mortality risk Klotho variants in dialysis patients


Condition Intervention
Dialysis
Genetic: blood sample

U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Prospective
Official Title: Genetic Determinants of Phosphocalcic Metabolism in Hemodialysis Patients

Further study details as provided by Hospices Civils de Lyon:

Primary Outcome Measures:
  • Assessing morbi-mortality based on Klotho variants [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Survival and serum phosphocalcic parameters [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

Biospecimen Description:

Searching for high morbi-mortality risk Klotho variants


Estimated Enrollment: 1200
Study Start Date: November 2008
Estimated Study Completion Date: November 2010
Groups/Cohorts Assigned Interventions
hemodialysis patients
Adult patients undergoing maintenance dialysis since at leat three months
Genetic: blood sample
Searching for Klotho variants in DNA

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Adult patients undergoing maintenance dialysis since at leat three months

Criteria

Inclusion Criteria:

  • Every adult > 18 years old and treated by dialysis in centers located in the Rhone Alpes area in France.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00858260

Contacts
Contact: FOUQUE Denis, MD denis.fouque@chu-lyon.fr

Locations
France
Hôpital Edouard Herriot Recruiting
LYON, France
Contact: FOUQUE Denis, MD            
Principal Investigator: FOUQUE Denis, MD            
Sponsors and Collaborators
Hospices Civils de Lyon
Investigators
Principal Investigator: FOUQUE Denis, MD Hospices Civils de Lyon
Principal Investigator: LEGRAND Eric, MD CH Annonay
Principal Investigator: KAARASLAN Huseyin, MD CH Bourgoin Jallieu
Principal Investigator: ABOKASEM Ayman, MD CH Chalon/saône
Principal Investigator: LATAILLADE Claire Dominique, MD CH Sallanches
Principal Investigator: KUENTZ François, MD Centre Dialyse eaux claires
Principal Investigator: HACHACHE Toufic, MD CHU Grenoble - La Tronche
Principal Investigator: LEITIENNE Philippe, MD Hospices Civils de Lyon
Principal Investigator: ARKOUCHE Walid, MD AURAL - Lyon
Principal Investigator: HEYANI Ahmed, MD CH MACON
Principal Investigator: HANNOUN Jacques, MD CH Villefranche/saône
Principal Investigator: COMBARNOUS François, MD Clinique du Tonkin VILLEURBANNE
Principal Investigator: MAUREAUGANDRY Xavier, MD AGDUC - Montélimar
Principal Investigator: SIRAJEDINE Mohamed, MD CH ROMANS/ISERE
Principal Investigator: JEAN Ahmed, MD Centre du Rein - Tassin la demi lune
Principal Investigator: DENICOLA Cora, MD Calydial - CH Viennes
  More Information

No publications provided

Responsible Party: Hospices Civils de Lyon ( Pr Denis FOUQUE )
Study ID Numbers: 2007.471/14
Study First Received: March 6, 2009
Last Updated: March 6, 2009
ClinicalTrials.gov Identifier: NCT00858260     History of Changes
Health Authority: France: Direction Générale de la Santé

Keywords provided by Hospices Civils de Lyon:
Klotho
calcium
phosphate
parathormone
survival
dialysis
Adult patients undergoing maintenance dialysis since at leat three months

Study placed in the following topic categories:
Calcium, Dietary

ClinicalTrials.gov processed this record on May 06, 2009